Michael E. Weinblatt
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.05%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 254
- Rheumatoid Arthritis Research and Therapies 231
- Systemic Lupus Erythematosus Research 44
- Immunology 47
- Biosimilars and Bioanalytical Methods 16
- Co-authors
- Nancy A. Shadick (103 shared papers)Robert M. Plenge (2 shared papers)Alkes L. Price (1 shared paper)David Reich (1 shared paper)David M. Lee (6 shared papers)Joel M. Kremer (23 shared papers)Daniel E. Fürst (11 shared papers)Edward Keystone (18 shared papers)
- Journals
- Annals of the Rheumatic Diseases (93 papers)Arthritis & Rheumatology (24 papers)Lara D. Veeken (18 papers)The Journal of Rheumatology (18 papers)Arthritis Research & Therapy (15 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Michael E. Weinblatt
380 papers receiving 34.0k citations
Michael E. Weinblatt's Hit Papers
Peers
Comparison fields: 5 of 201
- Rheumatology 16.0k
- Hematology 4.9k
- Immunology 5.8k
- Genetics 2.3k
- Genetics 4.6k
Countries citing papers authored by Michael E. Weinblatt
This map shows the geographic impact of Michael E. Weinblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Weinblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Weinblatt more than expected).
Fields of papers citing papers by Michael E. Weinblatt
This network shows the impact of papers produced by Michael E. Weinblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Weinblatt. The network helps show where Michael E. Weinblatt may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Weinblatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 386 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Principal components analysis corrects for stratification in genome-wide association studies Hit paper breakdown → | 2006 | 6674 |
| 2 | American college of rheumatology preliminary definition of improvement in rheumatoid arthritis Hit paper breakdown → | 1995 | 2272 |
| 3 | A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate Hit paper breakdown → | 1999 | 1693 |
| 4 | Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial Hit paper breakdown → | 2003 | 1472 |
| 5 | The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials Hit paper breakdown → | 1993 | 1351 |
| 6 | The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. Hit paper breakdown → | 1998 | 1225 |
| 7 | Rheumatoid arthritis Hit paper breakdown → | 2001 | 1081 |
| 8 | Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production Hit paper breakdown → | 2010 | 904 |
| 9 | Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis Hit paper breakdown → | 1985 | 738 |
| 10 | Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis Hit paper breakdown → | 2017 | 651 |
| 11 | Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2002 | 527 |
| 12 | Methotrexate for Rheumatoid Arthritis Hit paper breakdown → | 1994 | 479 |
| 13 | 2007 | 408 | |
| 14 | 2006 | 369 | |
| 15 | 2010 | 316 | |
| 16 | 2006 | 313 | |
| 17 | 2008 | 284 | |
| 18 | 1997 | 259 | |
| 19 | 2006 | 246 | |
| 20 | 2007 | 244 |
About Michael E. Weinblatt
Michael E. Weinblatt is a scholar working on Rheumatology, Immunology, Genetics, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 386 papers that have together received 35.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (231 papers), Systemic Lupus Erythematosus Research (44 papers), Chronic Lymphocytic Leukemia Research (43 papers), Autoimmune and Inflammatory Disorders Research (37 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), Lymphoma Diagnosis and Treatment (23 papers), Biosimilars and Bioanalytical Methods (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). The work is most often cited by research in Rheumatology (16.0k citations), Hematology (4.9k citations), Immunology (5.8k citations), Genetics (2.3k citations) and Genetics (4.6k citations). Michael E. Weinblatt has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Nancy A. Shadick, Robert M. Plenge, Alkes L. Price, David Reich, David M. Lee, Joel M. Kremer, Daniel E. Fürst, Edward Keystone, Roy Fleischmann and H. James Williams. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Lara D. Veeken, The Journal of Rheumatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.